EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Ebos Group's Enterprise Value is A$7,550 Mil.
Ebos Group's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2023 was A$230 Mil. Therefore, Ebos Group's EV-to-FCF for today is 32.81.
The historical rank and industry rank for Ebos Group's EV-to-FCF or its related term are showing as below:
ASX:EBO'
s EV-to-FCF Range Over the Past 10 Years
Min: 12.52 Med: 28.14 Max: 53.03
Current: 32.6
During the past 13 years, the highest EV-to-FCF of Ebos Group was 53.03. The lowest was 12.52. And the median was 28.14.
ASX:EBO's EV-to-FCF is ranked worse than 70.31% of 64
companies
in the Medical Distribution industry
Industry Median: 22.77
vs ASX:EBO: 32.60
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
As of today (2024-04-29), Ebos Group's stock price is A$32.02.
Ebos Group's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was A$1.352. Therefore, Ebos Group's PE Ratio for today is 23.68.
Ebos Group EV-to-FCF Historical Data
The historical data trend for Ebos Group's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Distribution subindustry, Ebos Group's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ebos Group's EV-to-FCF Distribution in the Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Ebos Group's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Ebos Group's EV-to-FCF falls into.
Ebos Group EV-to-FCF Calculation
Ebos Group's EV-to-FCF for today is calculated as:
Ebos Group's current Enterprise Value is A$7,550 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Ebos Group's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2023 was A$230 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ebos Group (ASX:EBO) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
Ebos Group's share price for today is A$32.02.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Ebos Group's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was A$1.352.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Ebos Group EV-to-FCF Related Terms
Thank you for viewing the detailed overview of Ebos Group's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.
Ebos is the largest pharmaceutical wholesaler and distributor across Australia and New Zealand. It services community pharmacies and hospitals, which contribute around 60% and 30% of revenue respectively. Drug pricing and wholesale margins for PBS medicine are governed by the Australian government's Pharmaceutical Benefits Scheme, or PBS. Wholesale gross margins are capped at 7% for community pharmacy and 10% for hospitals, and ongoing price reform typically results in low single digit revenue growth. Aside from pharma distribution, Ebos operates an animal health product wholesale, manufacturing and retail business, as well as undertaking third party logistics services. These segments are smaller contributors to group revenue but due to the unregulated nature are higher-margin operations.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
ASX:EBO has been successfully added to your 